PRFX PRF Technologies Ltd. (formerly PainReform Ltd.) Loading... : Investor Sentiment and Bull/Bear Views

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
17:00
Jan 12
u/Prior_Clothes9680 Reddit r/pennystocks
PRFX long on small float and safety news
The author argues $PRFX is primed for a momentum shift with good upside based on their technical analysis, and that today's news of a favorable safety profile for LayerBio's Drop-Less OcuRing-K delivery platform in preclinical and Phase I studies is a positive catalyst. They highlight the small 3.7M float as amplifying potential upside, suggesting it could be an end-of-day giant. No specific risk is stated.
PRFX 1ST
HIGH
15:39
Jan 12
u/Emotional_Type_3629 Reddit r/pennystocks
Long PRFX on Phase I safety data catalyst
The author argues PRFX just reported positive Phase I safety data for its OcuRing-K drop-less ocular drug platform, with no serious adverse events and proper device positioning in cataract surgery patients. The company tied the results to advancing toward an IND submission and Phase II development, and the author expects the news to catch on since the chart has not yet reacted. The author also notes the company owns DeepSolar, a commercial solar analytics platform, reducing dependence on OcuRing. Main risk implied is that the news has not yet been reflected in price.
PRFX
HIGH
15:30
Jan 12
u/Emotional_Type_3629 Reddit r/Baystreetbets
PRFX Phase I data, early chart reaction
The author argues PRFX's positive Phase I safety data for its OcuRing-K drop-less ocular drug platform (no serious adverse events, proper device positioning in cataract surgery) supports advancing toward an IND submission and Phase II development. The mechanism is replacing weeks of post-op eye drops with a single sustained-release solution placed during surgery, and the author notes the chart has not yet reacted. The author also notes the company owns DeepSolar, a commercial solar analytics platform, reducing dependence on OcuRing.
PRFX 1ST
HIGH

About PRFX Investor Commentary

Across the available history and selected sources, Buzzberg tracks PRFX (PRF Technologies Ltd. (formerly PainReform Ltd.)) across 2 sources: 3 bullish vs 0 bearish calls from 2 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 3 total trade ideas tracked. Latest voices: u/Prior_Clothes9680, u/Emotional_Type_3629.